Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 2,332.40
+27.95 (1.21%)
At close: Mar 5, 2026
Lupin Market Cap
Lupin has a market cap or net worth of 1.07 trillion as of March 5, 2026. Its market cap has increased by 15.33% in one year.
Market Cap
1.07T
Enterprise Value
1.07T
Revenue
261.51B
Ranking
n/a
PE Ratio
23.00
Stock Price
2,332.40
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 1.07T, an increase of 106,699.60%. That is a compound annual growth rate of 30.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 1.07T | 10.49% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.47T |
| Dr. Reddy's Laboratories | 1.09T |
| Abbott India | 586.38B |
| GlaxoSmithKline Pharmaceuticals | 420.53B |
| J. B. Chemicals & Pharmaceuticals | 332.47B |
| AstraZeneca Pharma India | 217.49B |
| Granules India | 137.16B |
| Jubilant Pharmova | 132.60B |